Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)

NCT00816660 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.

NCT NCT00816660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00816660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)
Lead sponsor
Baxalta now part of Shire
Phase
Phase 1
Overall status
Completed
Start date
December 1, 2008
Completion date
August 31, 2010
Enrollment
32 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

von willebrand disease